We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

137 hedge funds and large institutions have $329M invested in Spectrum Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

50% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 34

8% more funds holding

Funds holding: 127137 (+10)

8% less capital invested

Capital invested by funds: $359M → $329M (-$29.5M)

80% less call options, than puts

Call options by funds: $311K | Put options by funds: $1.58M

Holders
137
Holders Change
+10
Holders Change %
+7.87%
% of All Funds
3.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
25
Increased
51
Reduced
34
Closed
12
Calls
$311K
Puts
$1.58M
Net Calls
-$1.27M
Net Calls Change
-$113K
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$37.1M +$4.54M +617,551 +13%
Millennium Management
2
Millennium Management
New York
$32.3M -$257K -35,000 -0.7%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$29.4M
Vanguard Group
4
Vanguard Group
Pennsylvania
$28.7M +$1.3M +176,288 +4%
State Street
5
State Street
Massachusetts
$23.4M +$2.62M +355,934 +12%
BIT
6
BlackRock Institutional Trust
California
$14.4M +$782K +106,336 +5%
AC
7
Armistice Capital
New York
$14.2M +$15.1M +2,052,000 New
Goldman Sachs
8
Goldman Sachs
New York
$8.87M +$5.95K +809 +0.1%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$8.69M +$65.4K +8,900 +0.7%
ACM
10
Ashford Capital Management
Delaware
$8.03M +$1.21M +163,950 +16%
RCAMU
11
Rothschild & Co Asset Management US
Connecticut
$7.36M -$158K -21,451 -2%
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$7.14M +$196K +26,675 +3%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$6.27M -$75.3K -10,247 -1%
Barclays
14
Barclays
United Kingdom
$6.08M -$138K -18,798 -2%
Charles Schwab
15
Charles Schwab
California
$5.52M +$1.93M +262,574 +49%
Northern Trust
16
Northern Trust
Illinois
$5.03M -$142K -19,361 -3%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$4.06M -$75.1K -10,217 -2%
TA
18
Teachers Advisors
New York
$3.9M +$433K +58,900 +12%
Morgan Stanley
19
Morgan Stanley
New York
$3.9M +$3.07M +417,094 +288%
Macquarie Group
20
Macquarie Group
Australia
$3.34M +$557K +75,758 +19%
Wells Fargo
21
Wells Fargo
California
$3.24M -$184K -25,012 -5%
CS
22
Candriam SCA
Luxembourg
$2.77M +$2.94M +400,000 New
Principal Financial Group
23
Principal Financial Group
Iowa
$2.54M -$18K -2,449 -0.7%
PAM
24
Panagora Asset Management
Massachusetts
$2.48M +$97.1K +13,209 +4%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$2.3M +$251K +34,158 +11%

SPPI Hedge Fund Activity: Q4 2014 in Review

137 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2014, worth a combined $329M — down 8.2% from $359M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SPPI positions and 12 closed out — a net gain of 13 holders — while 51 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.54M. The largest seller was Bank of Montreal, cutting an estimated $9.99M.

  • 137 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2014, up from 127 in Q3 2014.
  • Funds reported $329M of Spectrum Pharmaceuticals Inc stock for Q4 2014, down 8.2% quarter-over-quarter.
  • 25 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2014 and 12 closed out, a net change of +13 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $4.54M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2014 was Bank of Montreal, an estimated $9.99M sold.

Based on aggregated 13F filings for Q4 2014.